Content
06/04/2024
Auburndale, MA USA
Axena Health
completed $9.4 million Series A Round funding. Investors include
Cross-Border Impact Ventures (lead), Avestria Ventures.
About
Bladder and bowel leaks are common in adult women, but they should not be considered "normal." Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders and is unapologetically focused on helping them live their best lives by harnessing the power of digital technology. Axena's Leva® Pelvic Health System helps women train and strengthen their pelvic floor muscles—at home, in just five minutes a day—to treat their stress, mixed and mild-to-moderate-urgency urinary incontinence (including overactive bladder) and chronic fecal incontinence. The Leva system’s patented mechanism of action is distinguished by published clinical evidence, peer-reviewed research and excellence in patient support. As a digital prescription therapeutic, the Leva system supports the critical partnership between clinicians and patients, shining a light on this important and underserved area of women’s health. The Leva® Pelvic Health System is available by prescription only. Do not use the Leva system while pregnant, or if you think you may be pregnant, unless authorized by your prescriber. Please talk to your prescriber to see if the Leva system is right for you.
Startup
Sector:
MedTech
Materials
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
